"You know I don’t eat in public,” Pat Merryman said to Wanda Patton, who are both heavily involved in the Columbus, OH, Parkinson’s disease (PD) community. They know people in every exercise class and attend every educational program. Pat keeps the Parkinson’s Foundation Ohio program manager’s business card with her to hand them out at every event she attends.
National Parkinson Foundation's blog
As winter melts into spring, you may be realizing that your exercise routine suffered through the cold season. You probably already know that exercise is a vital component to maintaining balance, mobility and daily living activities for people with Parkinson’s disease (PD).
Tom manages his Parkinson's disease (PD) symptoms by staying active, eating right and working with his health care team. He recently admitted to his doctor that when his wife isn't home he sometimes forgets to take his medication. His doctor recommended setting an alarm and using a pill organizer.
Eleanor was sitting at her friend Margaret’s house when she noticed a dog sniffing around the couch. She asked Margaret when she got the dog. Margaret said she didn’t have a dog. Eleanor realized she must be experiencing what her doctor warned her about when he increased her Parkinson’s disease (PD) medication dosage: hallucinations. She called her doctor that afternoon.
Before Miguel was diagnosed with Parkinson’s disease (PD) he often experienced A feeling of nervousness, worried thoughts and physical distress.. He retired early, but his anxiety would keep coming back, aggravating his tremor and making his thoughts race.
Mucuna pruriens variant utilis (MP) has long been used as an alternative to over the counter levodopa. MP is a leguminous plant that grows in both tropical and subtropical environments. Hidden in its seed is levodopa, which is the most important medication for a Parkinson’s disease patient. In this month’s What’s Hot we will review the studies supporting MP use and discuss future directions and global implications for this therapy.
There are approximately 3,000 movement disorder specialists in the world. While they are all neurologists, not all of them have experience treating Parkinson’s disease (PD). For every person with Parkinson’s to receive treatment from a specialist, each one of these doctors would have to treat more than 3,000 people with PD. Parkinson’s Foundation estimates that the average movement disorder specialist sees a total of 350 patients. That’s more than 8.9 million people with PD who are not being treated by a specialist.
Should we consider subcutaneous apomorphine infusions for Parkinson’s disease patients who do not want deep brain stimulation or a A chemical messenger (neurotransmitter) that regulates movement and emotions. pump? There is a growing interest among people with Parkinson’s disease (PD) and families for a “nonsurgical” alternative to
With medical marijuana legalized in 28 states and Washington, D.C., its therapeutic properties have become buzzworthy. Researchers are currently studying these properties and how they affect different diseases, like Parkinson’s disease (PD). But why?
Part of Steven Goldenthal’s job is to get people connected. He wants to know how they feel, gets to know their medical history, what medications they take and if they are happy with their Parkinson’s disease (PD) care.